Camber Launches Metformin Hydrochloride Oral Solution
Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add Metformin Hydrochloride Oral Solution [met-FOR-min] to its growing portfolio.
Metformin Hydrochloride Oral Solution is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
Metformin Hydrochloride Oral Solution is available in 500 mg/5 mL, 16 oz. bottles.
To learn more about this product, please visit: www.camberpharma.com/metformin
Recent articles
- Camber Launches Abacavir and Lamivudine Tablets, USP
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection





